Rodgers GP - Search Results

1

Pathophysiology of sickle cell disease: role of cellular and genetic modifiers.

Steinberg MH, Rodgers GP. Steinberg MH, et al. Among authors: rodgers gp. Semin Hematol. 2001 Oct;38(4):299-306. doi: 10.1016/s0037-1963(01)90023-x. Semin Hematol. 2001. PMID: 11605164 Review.

2

Hb Seal Rock [(alpha 2)142 term-->Glu, codon 142 TAA-->GAA]: an extended alpha chain variant associated with anemia, microcytosis, and alpha-thalassemia-2 (-3.7 Kb).

Merritt D, Jones RT, Head C, Thibodeau SN, Fairbanks VF, Steinberg MH, Coleman MB, Rodgers GP. Merritt D, et al. Among authors: rodgers gp. Hemoglobin. 1997 Jul;21(4):331-44. doi: 10.3109/03630269709000666. Hemoglobin. 1997. PMID: 9255612

3

Overview of pathophysiology and rationale for treatment of sickle cell anemia.

Rodgers GP. Rodgers GP. Semin Hematol. 1997 Jul;34(3 Suppl 3):2-7. Semin Hematol. 1997. PMID: 9317195 Review.

4

Pharmacologic modulation of fetal hemoglobin.

Steinberg MH, Rodgers GP. Steinberg MH, et al. Among authors: rodgers gp. Medicine (Baltimore). 2001 Sep;80(5):328-44. doi: 10.1097/00005792-200109000-00007. Medicine (Baltimore). 2001. PMID: 11552087 Free article. Review. No abstract available.

5

HbA2 : biology, clinical relevance and a possible target for ameliorating sickle cell disease.

Steinberg MH, Rodgers GP. Steinberg MH, et al. Among authors: rodgers gp. Br J Haematol. 2015 Sep;170(6):781-7. doi: 10.1111/bjh.13570. Epub 2015 Jun 24. Br J Haematol. 2015. PMID: 26104837 Free article. Review.

6

Use of selective vasodilation in treatment of sickle cell disease.

Rodgers GP, Roy MS, Noguchi CT, Schechter AN. Rodgers GP, et al. Am J Pediatr Hematol Oncol. 1988 Winter;10(4):351-6. doi: 10.1097/00043426-198824000-00018. Am J Pediatr Hematol Oncol. 1988. PMID: 3071169 Review.

7

Noninvasive techniques to evaluate the vaso-occlusive manifestations of sickle cell disease.

Rodgers GP, Noguchi CT, Schechter AN. Rodgers GP, et al. Am J Pediatr Hematol Oncol. 1985 Fall;7(3):245-53. doi: 10.1097/00043426-198507030-00007. Am J Pediatr Hematol Oncol. 1985. PMID: 3878101

8

Irreversibly sickled erythrocytes in sickle cell anemia: a quantitative reappraisal.

Rodgers GP, Noguchi CT, Schechter AN. Rodgers GP, et al. Am J Hematol. 1985 Sep;20(1):17-23. doi: 10.1002/ajh.2830200104. Am J Hematol. 1985. PMID: 4025318

9

Sickle cell rheology is determined by polymer fraction--not cell morphology.

Hiruma H, Noguchi CT, Uyesaka N, Hasegawa S, Blanchette-Mackie EJ, Schechter AN, Rodgers GP. Hiruma H, et al. Among authors: rodgers gp. Am J Hematol. 1995 Jan;48(1):19-28. doi: 10.1002/ajh.2830480105. Am J Hematol. 1995. PMID: 7832188

10

Sickle cell disease pathophysiology.

Noguchi CT, Schechter AN, Rodgers GP. Noguchi CT, et al. Among authors: rodgers gp. Baillieres Clin Haematol. 1993 Mar;6(1):57-91. doi: 10.1016/s0950-3536(05)80066-6. Baillieres Clin Haematol. 1993. PMID: 8353318 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters